BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tieu JD, Williams RJ, Skrepnek GH, Gentry CA. Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. J Clin Pharm Ther 2019;44:220-8. [DOI: 10.1111/jcpt.12771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wu KS, Syue LS, Cheng A, Yen TY, Chen HM, Chiu YH, Hsu YL, Chiu CH, Su TY, Tsai WL, Chen WY, Huang CH, Hung HM, Huang LJ, Kuo HJ, Lin PC, Yang CH, Hong PL, Lee SS, Chen YS, Liu YC, Huang LM; Infectious Diseases Society of Taiwan., Medical Foundation in Memory of Dr. Deh-Lin Cheng., Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education., CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines., 5th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group. Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan. J Microbiol Immunol Infect 2020;53:191-208. [PMID: 32169531 DOI: 10.1016/j.jmii.2020.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Rinaldi A, Reed EE, Stevenson KB, Coe K, Smith JM. Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent clostridioides difficile. J Clin Pharm Ther 2021;46:993-8. [PMID: 33609052 DOI: 10.1111/jcpt.13387] [Reference Citation Analysis]
3 Abdali ZI, Roberts TE, Barton P, Hawkey PM. Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection. EClinicalMedicine 2020;24:100420. [PMID: 32637898 DOI: 10.1016/j.eclinm.2020.100420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gentry CA, Campbell DL, Williams RJ. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study. Int J Antimicrob Agents 2021;57:106282. [PMID: 33465458 DOI: 10.1016/j.ijantimicag.2021.106282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Vent-Schmidt J, Attara GP, Lisko D, Steiner TS. Patient Experiences with Clostridioides difficile Infection: Results of a Canada-Wide Survey. Patient Prefer Adherence 2020;14:33-43. [PMID: 32021115 DOI: 10.2147/PPA.S229539] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]